Beyond Cholesterol: New Ways to Detect Heart Disease Earlier Than Ever

Heart disease remains the top cause of death in the United States. For decades, doctors have relied on cholesterol tests to assess risk, but newer methods now offer clearer warnings. Recent guidelines from leading health bodies highlight better ways to predict and prevent cardiovascular trouble before it starts.

The American Heart Association and American College of Cardiology have updated their advice over the past five years, moving beyond traditional cholesterol checks. New tools, including inflammation markers and advanced scans, are reshaping how doctors spot early signs of danger.

Cholesterol testing has been the standard for heart risk assessment since the 1950s. Yet research now shows that other factors often give a more accurate picture. Apolipoprotein B, which counts cholesterol particles in the blood, predicts heart disease better than standard LDL cholesterol readings. Another genetic marker, lipoprotein(a), also outperforms traditional cholesterol tests in forecasting risk.

Inflammation plays a key role in clogging arteries, a condition known as atherosclerosis. High levels of C-reactive protein (CRP), a sign of inflammation, signal greater heart risk—especially when readings exceed 3 milligrams per deciliter. The American College of Cardiology now recommends checking CRP alongside cholesterol for everyone.

Recent guidelines reflect this shift. In September 2025, the ACC widened statin eligibility for adults with moderate risk if their coronary artery calcium (CAC) score is above zero. Earlier rules from 2018 and 2019 relied mostly on pooled risk equations and narrower criteria. Other groups, like the European Society of Cardiology, have adopted similar imaging-based risk checks. The AHA's 2023 updates also included social factors and AI tools to tailor screening more precisely.

Lifestyle changes can lower CRP levels and reduce risk. Diet, regular exercise, and weight management all help keep inflammation in check. But experts stress that prevention works best when people understand all their risk factors—not just cholesterol numbers.

The push for broader testing comes as heart disease continues to claim more lives than any other condition. Early detection through CAC scans, CRP checks, and genetic markers gives doctors a clearer view of who needs treatment sooner. This approach marks a major change from past decades, when cholesterol alone guided decisions.

The latest guidelines mean more people could qualify for early treatment based on advanced risk assessments. Doctors now have stronger tools to identify hidden dangers before symptoms appear. With heart disease still the nation's biggest killer, these updates aim to save lives by catching problems earlier and tailoring prevention more effectively.